Bitrue has listed three new USDT-margined perpetual contracts tracking defense contractor Northrop Grumman (NOC), the semiconductor-focused SOXX index, and energy producer ConocoPhillips (COP), giving users derivative exposure to three distinct sectors of the traditional stock market directly through the exchange. The listings add to Bitrue's existing lineup of tokenized-equity perpetuals, extending the exchange's push into so-called TradFi perps alongside its core crypto futures offering.

The launch places Bitrue inside a market that has grown sharply over the past year and a half. According to CoinGecko's TradFi-on-crypto-exchanges research, monthly volume in tokenized-equity perpetuals climbed from roughly $831 million in July 2025 to about $34 billion in May 2026, a nearly 40-fold increase, as exchanges raced to list contracts on individual stocks, sector indexes and commodities. Binance, MEXC and Hyperliquid currently lead the category by volume, with Binance alone processing close to $499 billion in TradFi perps trading over the same 17-month stretch.

Bitrue Adds Defense, Chip and Energy Stocks to Its Perpetuals Menu
Image via @BitrueOfficial on X

Why Exchanges Keep Adding These Products

The appeal for exchanges is straightforward: TradFi perpetuals let crypto-native traders take leveraged positions on stocks and sector benchmarks without needing a traditional brokerage account, all inside the same interface and wallet they already use for crypto trading. Perpetual contracts on tokenized assets have also outpaced spot tokenized real-world assets by a wide margin industry-wide, suggesting most of the demand in this category is for flexible, leveraged derivative exposure rather than actual ownership of the underlying tokenized shares.

What Traders Should Weigh

NOC, SOXX and COP give Bitrue users exposure to three separate macro narratives at once — defense spending, semiconductor demand and energy prices — through a single product type. As with any perpetual contract, leverage magnifies both gains and losses, and traders taking positions on these instruments are exposed to funding-rate costs and liquidation risk in addition to the price moves of the underlying stocks themselves, on top of the platform and counterparty risk inherent to trading synthetic exposure rather than the shares directly.